A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
REal World ExperieNce With BRIUMVI® (UblituximAB-xiiy) Treated Patients: A Longitudinal REgistry Study (ENABLE)
- Relapsing Multiple Sclerosis
- Multiple Sclerosis
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- TG Therapeutics, Inc.
- Enrolment target
- 2,000
- Started
- 22 July 2024
- Main results due
- 1 April 2032
- Study sites
- 111
- Registry updated
- 23 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Confirmed Multiple Sclerosis (MS) diagnosis. 2. Participants who have not received any BRIUMVI® (ublituximab-xiiy) infusion prior to study start. Participants who have been prescribed BRIUMVI® (ublituximab-xiiy) but have not yet received their first infusion on Day 1 of 150 milligrams (mg) can be included. Exclusion Criteria: 1. Have received any live or live-attenuated vaccines (including for varicella-zoster virus or measles) within 4 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration or any non-live vaccines within 2 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration. 2. Any active infection (e.g., active Hepatitis B virus \[HBV\]) 3. Concurrent participation in any interventional MS trials, or planned concurrent treatment with other Multiple Sclerosis Disease Modifying Therapy (MS DMT) during the study period.
What this study is about
In the sponsor’s own words, from the registry.
The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting
Study sites(111)
TG Therapeutics Investigational Trial Site
Birmingham, Alabama, United States
Recruiting
TG Therapeutics Investigational Trial Site
Cullman, Alabama, United States
Recruiting
TG Therapeutics Investigational Trial Site
Huntsville, Alabama, United States
Recruiting
TG Therapeutics Investigational Trial Site
Mobile, Alabama, United States
Recruiting
TG Therapeutics Investigational Trial Site
Gilbert, Arizona, United States
Recruiting
TG Therapeutics Investigational Trial Site
Phoenix, Arizona, United States
Recruiting
TG Therapeutics Investigational Trial Site
Scottsdale, Arizona, United States
Recruiting
TG Therapeutics Investigational Trial Site
Fresno, California, United States
Recruiting
TG Therapeutics Investigational Trial Site
Newport Beach, California, United States
Recruiting
TG Therapeutics Investigational Trial Site
Orange, California, United States
Recruiting
TG Therapeutics Investigational Trial Site
West Hollywood, California, United States
Recruiting
TG Therapeutics Investigational Trial Site
Aurora, Colorado, United States
Recruiting
TG Therapeutics Investigational Trial Site
Basalt, Colorado, United States
Recruiting
TG Therapeutics Investigational Trial Site
Colorado Springs, Colorado, United States
Recruiting
TG Therapeutics Investigational Trial Site
Colorado Springs, Colorado, United States
Recruiting
TG Therapeutics Investigational Trial Site
Denver, Colorado, United States
Recruiting
TG Therapeutics Investigational Trial Site
Fort Collins, Colorado, United States
Recruiting
TG Therapeutics Investigational Trial Site
Grand Junction, Colorado, United States
Recruiting
TG Therapeutics Investigational Trial Site
Farmington, Connecticut, United States
Recruiting
TG Therapeutics Investigational Trial Site
Hartford, Connecticut, United States
Recruiting
TG Therapeutics Investigational Trial Site
Washington D.C., District of Columbia, United States
Recruiting
TG Therapeutics Investigational Trial Site
Altamonte Springs, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Boca Raton, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Clearwater, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Gainesville, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Maitland, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Miami, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Naples, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Orlando, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Pensacola, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Weston, Florida, United States
Recruiting
TG Therapeutics Investigational Trial Site
Atlanta, Georgia, United States
Recruiting
TG Therapeutics Investigational Trial Site
Atlanta, Georgia, United States
Recruiting
TG Therapeutics Investigational Trial Site
Savannah, Georgia, United States
Recruiting
TG Therapeutics Investigational Trial Site
Smyrna, Georgia, United States
Recruiting
TG Therapeutics Investigational Trial Site
Honolulu, Hawaii, United States
Recruiting
TG Therapeutics Investigational Trial Site
Coeur d'Alene, Idaho, United States
Recruiting
TG Therapeutics Investigational Trial Site
Chicago, Illinois, United States
Recruiting
TG Therapeutics Investigational Trial Site
Chicago, Illinois, United States
Recruiting
TG Therapeutics Investigational Trial Site
Evanston, Illinois, United States
Recruiting
TG Therapeutics Investigational Trial Site
Urbana, Illinois, United States
Recruiting
TG Therapeutics Investigational Trial Site
Avon, Indiana, United States
Recruiting
TG Therapeutics Investigational Trial Site
Roeland Park, Kansas, United States
Recruiting
TG Therapeutics Investigational Trial Site
Lexington, Kentucky, United States
Recruiting
TG Therapeutics Investigational Trial Site
Louisville, Kentucky, United States
Recruiting
TG Therapeutics Investigational Trial Site
Baltimore, Maryland, United States
Recruiting
TG Therapeutics Investigational Trial Site
Glen Burnie, Maryland, United States
Recruiting
TG Therapeutics Investigational Trial Site
Boston, Massachusetts, United States
Recruiting
TG Therapeutics Investigational Trial Site
Burlington, Massachusetts, United States
Recruiting
TG Therapeutics Investigational Trial Site
Norfolk, Massachusetts, United States
Recruiting
TG Therapeutics Investigational Trial Site
Ann Arbor, Michigan, United States
Recruiting
TG Therapeutics Investigational Trial Site
Detroit, Michigan, United States
Recruiting
TG Therapeutics Investigational Trial Site
Farmington, Michigan, United States
Recruiting
TG Therapeutics Investigational Trial Site
Owosso, Michigan, United States
Recruiting
TG Therapeutics Investigational Trial Site
Rochester Hills, Michigan, United States
Recruiting
TG Therapeutics Investigational Trial Site
Golden Valley, Minnesota, United States
Recruiting
TG Therapeutics Investigational Trial Site
Plymouth, Minnesota, United States
Recruiting
TG Therapeutics Investigational Trial Site
Billings, Montana, United States
Recruiting
TG Therapeutics Investigational Trial Site
Lincoln, Nebraska, United States
Recruiting
TG Therapeutics Investigational Trial Site
Omaha, Nebraska, United States
Recruiting
Showing 60 of 111 sites — filter to narrow it down. 111 of the 111 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06433752. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me